Related Experiment Video
Updated: Jul 16, 2025
Derivation of Glial Restricted Precursors from E13 mice
Published on: June 20, 2012
Oligodendrocyte Progenitor Cell Transplantation Ameliorates Preterm Infant Cerebral White Matter Injury in Rats Model
Zhaoyan Wang1, Leping Zhang1,2, Yinxiang Yang1
1Laboratory of Pediatrics, The Sixth Medical Center of PLA General Hospital, Beijing, 100048, People's Republic of China.
Insights
Cell replacement therapy using human oligodendrocyte progenitor cells (hOPCs) shows promise for treating white matter injury (WMI) in preterm infants. Transplanted hOPCs repaired brain lesions and improved cognitive functions in a rat model.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Developmental Pediatrics
Background:
- Cerebral white matter injury (WMI) is a significant cause of motor and cognitive deficits in preterm infants.
- Current treatments for WMI are limited, highlighting the need for novel therapeutic strategies.
- Cell replacement therapy using oligodendrocyte progenitor cells (OPCs) is a promising approach for WMI.
Purpose of the Study:
- To develop a method for differentiating human neural stem cells (hNSCs) into human OPCs (hOPCs).
- To evaluate the efficacy of transplanted hOPCs in a preterm WMI rat model.
- To assess the impact of hOPC transplantation on cognitive function recovery.
Main Methods:
- Established a preterm WMI rat model on postnatal day 3.
- Differentiated hNSCs into hOPCs and transplanted them into the corpus callosum on postnatal day 10.
- Utilized histological analysis, electron microscopy, and behavioral assays (Morris water maze) to assess outcomes.
Main Results:
- Transplanted hOPCs survived, migrated, and differentiated into mature oligodendrocytes (OLS) within the WMI brain.
- Histological analysis confirmed structural repair of white matter lesions.
- Electron microscopy demonstrated remyelination of axons, and behavioral tests showed significant cognitive function recovery.
Conclusions:
- Exogenous hOPCs can differentiate into OLS in the WMI rat brain.
- hOPC transplantation effectively repairs white matter lesions and improves cognitive functions.
- This study supports cell replacement therapy as a viable treatment for WMI.
Background:
Cerebral white matter injury (WMI) is the most common brain injury in preterm infants, leading to motor and developmental deficits often accompanied by cognitive impairment. However, there is no effective treatment. One promising approach for treating preterm WMI is cell replacement therapy, in which lost cells can be replaced by exogenous oligodendrocyte progenitor cells (OPCs).
Methods:
This study developed a method to differentiate human neural stem cells (hNSCs) into human OPCs (hOPCs). The preterm WMI animal model was established in rats on postnatal day 3, and OLIG2+/NG2+/PDGFRα+/O4+ hOPCs were enriched and transplanted into the corpus callosum on postnatal day 10. Then, histological analysis and electron microscopy were used to detect lesion structure; behavioral assays were performed to detect cognitive function.
Results:
Transplanted hOPCs survived and migrated throughout the major white matter tracts. Morphological differentiation of transplanted hOPCs was observed. Histological analysis revealed structural repair of lesioned areas. Re-myelination of the axons in the corpus callosum was confirmed by electron microscopy. The Morris water maze test revealed cognitive function recovery.
Conclusion:
Our study showed that exogenous hOPCs could differentiate into CC1+ OLS in the brain of WMI rats, improving their cognitive functions.
